Metis Global Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Sell |
10,736
-1,205
| -10% | -$469K | 0.11% | 162 |
|
|
2025
Q1 | $5.19M | Buy |
11,941
+1,495
| +14% | +$650K | 0.15% | 122 |
|
|
2024
Q4 | $3.85M | Sell |
10,446
-1,618
| -13% | -$597K | 0.12% | 148 |
|
|
2024
Q3 | $6.27M | Buy |
12,064
+992
| +9% | +$516K | 0.2% | 85 |
|
|
2024
Q2 | $6M | Buy |
11,072
+216
| +2% | +$117K | 0.21% | 75 |
|
|
2024
Q1 | $5.63M | Buy |
10,856
+36
| +0.3% | +$18.7K | 0.2% | 78 |
|
|
2023
Q4 | $5.1M | Sell |
10,820
-721
| -6% | -$340K | 0.2% | 85 |
|
|
2023
Q3 | $5.03M | Buy |
11,541
+1,626
| +16% | +$708K | 0.24% | 72 |
|
|
2023
Q2 | $4.41M | Buy |
9,915
+88
| +0.9% | +$39.1K | 0.24% | 81 |
|
|
2023
Q1 | $4.52M | Buy |
9,827
+2,116
| +27% | +$973K | 0.29% | 69 |
|
|
2022
Q4 | $3.96M | Buy |
7,711
+3,412
| +79% | +$1.75M | 0.35% | 60 |
|
|
2022
Q3 | $1.95M | Buy |
4,299
+295
| +7% | +$134K | 0.31% | 68 |
|
|
2022
Q2 | $1.93M | Buy |
4,004
+172
| +4% | +$83K | 0.31% | 73 |
|
|
2022
Q1 | $1.88M | Buy |
3,832
+1,707
| +80% | +$838K | 0.23% | 86 |
|
|
2021
Q4 | $985K | Buy |
+2,125
| New | +$985K | 0.27% | 84 |
|